| __timestamp | BeiGene, Ltd. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21862000 | 22223073 |
| Thursday, January 1, 2015 | 58250000000 | 6966842 |
| Friday, January 1, 2016 | 98033000 | 9000499 |
| Sunday, January 1, 2017 | 269018000 | 13741186 |
| Monday, January 1, 2018 | 679005000 | 19040000 |
| Tuesday, January 1, 2019 | 927338000 | 23559000 |
| Wednesday, January 1, 2020 | 1294877000 | 31931000 |
| Friday, January 1, 2021 | 1459239000 | 44981000 |
| Saturday, January 1, 2022 | 1640508000 | 54234000 |
| Sunday, January 1, 2023 | 1778594000 | 63806000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, BeiGene, Ltd. and Viking Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Since 2014, BeiGene has consistently increased its R&D expenses, peaking in 2015 with a staggering 58 billion USD, reflecting its aggressive pursuit of groundbreaking therapies. In contrast, Viking Therapeutics has maintained a more conservative R&D budget, with a steady increase from 7 million USD in 2015 to 64 million USD in 2023, marking a nearly 800% growth.
This comparison highlights the diverse strategies within the biotech sector, where both high and moderate R&D investments can lead to significant advancements in medical science.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and BeiGene, Ltd.
R&D Insights: How Novartis AG and BeiGene, Ltd. Allocate Funds
Comparing Innovation Spending: Gilead Sciences, Inc. and BeiGene, Ltd.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
BeiGene, Ltd. vs Pharming Group N.V.: Strategic Focus on R&D Spending
Comparing Innovation Spending: BeiGene, Ltd. and Ultragenyx Pharmaceutical Inc.
R&D Spending Showdown: BeiGene, Ltd. vs ADMA Biologics, Inc.
Comparing Innovation Spending: BeiGene, Ltd. and Viridian Therapeutics, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs Viking Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs MannKind Corporation